Skip to main content
. 1998 Aug;36(8):2301–2307. doi: 10.1128/jcm.36.8.2301-2307.1998

TABLE 1.

Prevalence of chlamydia-reactive antibody determined by MIF assay and rDNA LPS ELISA

Study population No. of subjects Prevalence (%) observed by the following:
rDNA LPS ELISAa
MIF assay rDNA LPS ELISA Sensitivity (%) Specificity (%) NPV (%) PPV (%)
Blood donors 1,104 71.2 29.4 33.5 80.5 32.9 80.9
COPD patients 271 72.0 53.1b 64.1 75.0 44.9 86.8
a

The MIF assay was used as the gold standard. 

b

P < 0.0001 compared to blood donors.